Estrogens
In clinical developmentAlso known as Estrogen receptor agonist, Estrogen.
Recent clinical, regulatory, research and industry developments relating to this drug.
Impact of FSH and Estradiol on Sympathetic Function in Menopausal Women
A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion
Early Neurovascular Adaptations in Aging Women
The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy.
Hormone Replacement Therapy and Cardiovascular Health in Postmenopausal Women.
The Estrogen-Immune Interface in Endometriosis.
Associations Among Estrogens, the Gut Microbiome and Osteoporosis.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Impact of FSH and Estradiol on Sympathetic Function in Menopausal Women
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences5
- Frontiers in endocrinology2
- Frontiers in immunology2
- Journal of neuroinflammation2
- Annals of internal medicine1
- Annals of oncology : official journal of the European Society for Medical Oncology1
- Abdi HI1
- Ajila T1
- Allison KH1
- Amirkhanova A1
- Andy C1
- Anthony M1
- Ayhan A1
- Bacci M1
- School of Medicine2
- "Almaty City Hospital No. 29" Communal State Enterprise on the Right of Economic Management1
- Albert Einstein College of Medicine1
- American Society of Clinical Oncology1
- Ankara Etlik City Hospital1
- BioFrontiers Institute1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 14 of the same disease areas as Estrogens in the shared literature.
Studied across 11 of the same disease areas as Estrogens in the shared literature.
Studied across 10 of the same disease areas as Estrogens in the shared literature.
Studied across 5 of the same disease areas as Estrogens in the shared literature.
Studied across 4 of the same disease areas as Estrogens in the shared literature.
Studied across 4 of the same disease areas as Estrogens in the shared literature.
Studied across 3 of the same disease areas as Estrogens in the shared literature.
Studied across 3 of the same disease areas as Estrogens in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials